Catalyst Pharmaceuticals position history
The shares of Catalyst Pharmaceuticals that Fundsmith LLP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q1: 2,151,274 shares, $52M, 0.24% of portfolio, New
- 2025 Q2: 2,709,086 shares, $59M, 0.26% of portfolio, Add +25.9%
- 2025 Q3: 3,363,807 shares, $66M, 0.33% of portfolio, Add +24.2%
- 2025 Q4: 3,363,807 shares, $79M, 0.46% of portfolio
- 2026 Q1: 844,887 shares, $21M, 0.16% of portfolio, Reduce −74.9%
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|